Arrowhead Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Pasadena CA United States (2004)

Organization Overview

First Clinical Trial
2013
NCT01872065
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Arrowhead Pharmaceuticals | Arrowhead Pharmaceuticals, Inc.